SmallCaps
ASX:CGSHealth Care Equipment & ServicesHealth Care Technology

COGSTATE ORD

$2.160
$0.010 (0.46%)
Day Range
$2.140 - $2.190
52 Week Range
$1.210 - $2.970
Volume
169.03K
Avg Volume (10D)
99.00K
Market Cap
$370.56M
P/E Ratio
26.25
Price Chart
Market Statistics
Open$2.180
Previous Close$2.170
Day High$2.190
Day Low$2.140
52 Week High$2.970
52 Week Low$1.210
Valuation
Market Cap370.56M
Shares Outstanding171.55M
P/E Ratio (Annual)26.25
P/E Ratio (TTM)24.88
Dividend Yield0.93%
Price to Book5.09
Trading Activity
Volume169.03K
Value Traded365.50K
Bid$2.160 × 26,972
Ask$2.200 × 733
Performance
1 Day-0.46%
5 Day0.47%
13 Week-12.90%
52 Week54.29%
YTD-4.42%
Technical Indicators
RSI (14)47.48
50-Day SMA$2.191
200-Day SMA$2.103
Latest News
Cogstate achieves best half year on record for clinical trial sales
Biotechnology

Cogstate achieves best half year on record for clinical trial sales

Neuroscience technology company Cogstate (ASX: CGS) revealed it has executed US$26.8 million (A$38.88 million) in clinical trial sales contracts for the 2020 financial year to date – making it the company’s best half year result on record. During the September quarter, Cogstate clocked US$7.7 million (A$11.17 million) in clinical trial sales contracts and has followed […]

1 min read
Lorna Nicholas
Lorna Nicholas